Drug survival of adalimumab and infliximab in hidradenitis suppurativa patients: a daily practice cohort study

被引:0
|
作者
Prens, Lisette M. [1 ]
Bouwman, Klasiena [1 ]
Aarts, Pim [2 ]
Arends, Suzanne [3 ]
van Straalen, Kelsey R. [2 ]
Dudink, Koen [2 ]
van der Zee, Hessel H. [2 ]
Prens, Errol P. [2 ]
Horvath, Barbara [1 ]
机构
[1] Univ Med Ctr Groningen, Dermatol, Groningen, Netherlands
[2] Univ Med Ctr Rotterdam, Dermatol, Rotterdam, Netherlands
[3] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
50
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [41] Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa
    Cao, Y.
    Hong, F.
    Conlon, D. M.
    Sidur, L.
    Smith, K. M.
    Fang, Y.
    Cuff, C. A.
    Kaymakcalan, Z.
    Ruzek, M. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (04) : 804 - 814
  • [42] Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
    van den Reek, Juul M. P. A.
    van Vugt, Lieke J.
    van Doorn, Martijn B. A.
    van der Kraaij, Gayle E.
    de Kort, Wim J. A.
    Lucker, Georges P. H.
    Horvath, Barbara
    Njoo, M. David
    Bovenschen, H. Jorn
    Ossenkoppele, Paul M.
    De Bruin-Weller, Marjolein S.
    de Groot, Marjan
    Mommers, Roland
    Prevoo, Ruud L. M. A.
    van de Kerkhof, Peter C. M.
    Spuls, Phyllis I.
    Kievit, Wietske
    de Jong, Elke M. G. J.
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (07) : 648 - 654
  • [43] Switching from intravenous to subcutaneous infliximab in patients with hidradenitis suppurativa
    Luque, Mar
    Barboza, Lorenza
    Sandoval, Alejandra
    Fuertes, Irene
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 145 - 145
  • [44] Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice
    Tzellos, Thrasyvoulos
    Zouboulis, Christos C.
    DERMATOLOGY AND THERAPY, 2020, 10 (01) : 63 - 71
  • [45] Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice
    Thrasyvoulos Tzellos
    Christos C. Zouboulis
    Dermatology and Therapy, 2020, 10 : 63 - 71
  • [46] Efficacy of Infliximab treatment in patients with severe Fistulizing Hidradenitis Suppurativa
    Elkjaer, Margarita
    Dinesen, Lotte
    Benazzato, Luca
    Rodriguez, Jaime
    Logager, Vibeke
    Munkholm, Pia
    JOURNAL OF CROHNS & COLITIS, 2008, 2 (03): : 241 - 245
  • [47] Effectiveness of adalimumab in hidradenitis suppurativa: A real-world study
    Magdalena Moneva-Leniz, Lya
    Garcia-Ruiz, Ramon
    Sanchez Martinez, Eva Maria
    Gegundez Hernandez, Hector
    Melgosa Ramos, Javier
    Garcia Briz, Maria Isabel
    Mateu Puchades, Almudena
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB143 - AB143
  • [48] Identifying anaemia in a cohort of patients with hidradenitis suppurativa
    Soliman, Y. S.
    Chaitowitz, M.
    Hoffman, L. K.
    Lin, J.
    Lowes, M. A.
    Cohen, S. R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : E5 - E8
  • [49] Characterizing a cohort of pediatric patients with hidradenitis suppurativa
    Babbush, K.
    Waldman, A.
    Ghias, M.
    Nosrati, A.
    Pacific, K.
    Lee, D.
    Cohen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S59 - S59
  • [50] Hidradenitis suppurativa/Acne inversa in der PraxisHidradenitis suppurativa/acne inversa in daily practice
    H. Kurzen
    K. Fritz
    A. Altenburg
    Der Hautarzt, 2021, 72 : 706 - 714